Walleye Capital’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Walleye Capital's HALO Position: Q2 2026 in Review
Walleye Capital reduced its Halozyme (HALO) stake by 18% in Q2 2026, selling an estimated $647K and leaving 43,871 shares worth $3.43M. The position accounts for 0.01% of the portfolio, ranked #1077.
Walleye Capital first reported a position in HALO in Q2 2019 and has held it in 15 quarters since. The position peaked at $9.81M in Q2 2024. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Walleye Capital held 43,871 shares of Halozyme worth $3.43M as of Q2 2026.
- Walleye Capital sold 9,493 Halozyme shares in Q2 2026, an estimated $647K.
- Halozyme made up 0.01% of Walleye Capital's portfolio in Q2 2026, its #1077 holding.
- Walleye Capital first reported a position in Halozyme in Q2 2019 and has held it in 15 quarters since.
- Walleye Capital's Halozyme position peaked at $9.81M in Q2 2024.
- 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.